[MgSO4 therapy in severe pre-eclampsia/eclampsia]
- PMID: 2180240
[MgSO4 therapy in severe pre-eclampsia/eclampsia]
Abstract
Corresponding to the newer literature and based on good own experiences lasting for four decades magnesium sulfate is put out as anticonvulsive drug of first choice in cases of severe preeclampsia and eclampsia. Especially the dosage is explained in connection with the classic schemes of Pritchard and Zuspan, in which a high concentration of magnesium in serum situated in therapeutic range is aspired to without additional sedatives. As standard dose initially 4 g MgSO4, followed by 2 g/h intravenously (in severe cases in the first hours 3 g/h) for continuing serum level applied by infusion pump are recommended. Dihydralazine as most used drug shall be applied by a second pump. Besides some newer results about the effects of magnesium sulfate on mother and child are mentioned.
Similar articles
-
Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia.Obstet Gynecol. 1981 Feb;57(2):199-202. Obstet Gynecol. 1981. PMID: 7465124
-
Eclampsia: treatment and referral.South Med J. 1982 Mar;75(3):267-9. South Med J. 1982. PMID: 7063897
-
The use of magnesium sulfate in preeclampsia-eclampsia.J Reprod Med. 1979 Sep;23(3):107-14. J Reprod Med. 1979. PMID: 490496 No abstract available.
-
The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia.Ann Afr Med. 2009 Apr-Jun;8(2):76-80. doi: 10.4103/1596-3519.56232. Ann Afr Med. 2009. PMID: 19805935 Review.
-
Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.Clin Pharmacokinet. 2000 Apr;38(4):305-14. doi: 10.2165/00003088-200038040-00002. Clin Pharmacokinet. 2000. PMID: 10803454 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials